インスリン様成長因子1
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2023/11/19 05:04 UTC 版)
インスリン様成長因子1（インスリンようせいちょういんし1、英: Insulin-like growth factor 1、略称: IGF-1、IGF-I）は、インスリンに類似した分子構造を持つホルモンである。小児の成長に重要な役割を果たし、成人においても同化作用を有する。ソマトメジンC（somatomedin C）とも呼ばれる。
- ^ a b c GRCh38: Ensembl release 89: ENSG00000017427 - Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000020053 - Ensembl, May 2017
- ^ Human PubMed Reference:
- ^ Mouse PubMed Reference:
- ^ “The human gene encoding insulin-like growth factor I is located on chromosome 12”. Hum. Genet. 69 (2): 157–60. (1985). doi:10.1007/BF00293288. PMID 2982726.
- ^ “Sequence of cDNA encoding human insulin-like growth factor I precursor”. Nature 306 (5943): 609–11. (1983). doi:10.1038/306609a0. PMID 6358902.
- ^ “The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin”. J Biol Chem 253 (8): 2769–2776. (1978). PMID 632300.
- ^ “Mecasermin”. BioDrugs 22 (3): 177–88. (2008). doi:10.2165/00063030-200822030-00004. PMID 18481900.
- ^ “Negative cooperativity in the insulin-like growth factor-I receptor and a chimeric IGF-I/insulin receptor”. Endocrinology 135 (1): 472–5. (July 1994). doi:10.1210/endo.135.1.8013387. PMID 8013387.
- ^ “Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population”. Cell Metabolism 19 (3): 407–17. (March 2014). doi:10.1016/j.cmet.2014.02.006. PMC 3988204. PMID 24606898.
- ^ “Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review”. Xenobiotica 36 (2–3): 119–218. (2006). doi:10.1080/00498250600621627. PMID 16702112.
- ^ “Circulating levels of IGF-1 directly regulate bone growth and density”. Journal of Clinical Investigation 110 (6): 771–781. (2002). doi:10.1172/JCI15463. PMC 151128. PMID 12235108.
- ^ “Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis”. Molecular and Cellular Biology 19 (10): 7203–15. (October 1999). doi:10.1128/mcb.19.10.7203. PMC 84713. PMID 10490655.
- ^ “c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release”. Genes & Development 13 (11): 1367–81. (June 1999). doi:10.1101/gad.13.11.1367. PMC 316765. PMID 10364155.
- ^ “Mechano-growth factor reduces loss of cardiac function in acute myocardial infarction”. Heart Lung Circ 17 (1): 33–9. (February 2008). doi:10.1016/j.hlc.2007.04.013. PMID 17581790.
- ^ “Ecuadorean Villagers May Hold Secret to Longevity”. New York Times (2011年2月17日). 2019年12月8日閲覧。
- ^ “Expert consensus document: A consensus on the medical treatment of acromegaly”. Nat Rev Endocrinol 10 (4): 243–8. (2014). doi:10.1038/nrendo.2014.21. PMID 24566817.
- ^ a b “The role of recombinant insulin-like growth factor I in the treatment of the short child”. Curr. Opin. Pediatr. 19 (4): 458–64. (2007). doi:10.1097/MOP.0b013e3282094126. PMID 17630612.
- ^ "Genentech Discontinues IGF-I Drug Development Effort in Diabetes" (Press release). Genentech. 5 September 1997. 2013年3月15日閲覧。
- ^ “Assessment of Mechanisms of Improved Wound Healing - Full Text View - ClinicalTrials.gov” (英語). clinicaltrials.gov. 2019年12月14日閲覧。
- ^ Heatwole, Chad R.; Eichinger, Katy J.; Friedman, Deborah I.; Hilbert, James E.; Jackson, Carlayne E.; Logigian, Eric L.; Martens, William B.; McDermott, Michael P. et al. (2011-01). “Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1”. Archives of Neurology 68 (1): 37–44. doi:10.1001/archneurol.2010.227. ISSN 1538-3687. PMC 3374954. PMID 20837825.
- ^ Lai, E. C.; Felice, K. J.; Festoff, B. W.; Gawel, M. J.; Gelinas, D. F.; Kratz, R.; Murphy, M. F.; Natter, H. M. et al. (1997-12). “Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group”. Neurology 49 (6): 1621–1630. doi:10.1212/wnl.49.6.1621. ISSN 0028-3878. PMID 9409357.
- ^ Borasio, G. D.; Robberecht, W.; Leigh, P. N.; Emile, J.; Guiloff, R. J.; Jerusalem, F.; Silani, V.; Vos, P. E. et al. (1998-08). “A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group”. Neurology 51 (2): 583–586. doi:10.1212/wnl.51.2.583. ISSN 0028-3878. PMID 9710040.
- ^ Sorenson, E. J.; Windbank, A. J.; Mandrekar, J. N.; Bamlet, W. R.; Appel, S. H.; Armon, C.; Barkhaus, P. E.; Bosch, P. et al. (2008-11-25). “Subcutaneous IGF-1 is not beneficial in 2-year ALS trial”. Neurology 71 (22): 1770–1775. doi:10.1212/01.wnl.0000335970.78664.36. ISSN 1526-632X. PMC 2617770. PMID 19029516.
- ^ “Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial”. Neurology 71 (21): 1702–8. (November 2008). doi:10.1212/01.wnl.0000335163.88054.e7. PMID 19015485.
- ^ “Growth Drug Is Caught Up in Patent Fight”. The New York Times (2007年2月17日). 2010年3月28日閲覧。
- ^ “To Settle Suit, Maker Agrees to Withdraw Growth Drug”. The New York Times (2007年3月7日). 2010年3月28日閲覧。
- ^ Jaslow R (2013年1月30日). “Deer-antler spray: What is IGF-1?”. CBS News. 2019年12月14日閲覧。
- ^ Rovell D (9 August 2011). "Deer Antler Velvet Sales On The Rise, Does It Really Work?". CNBC.com
- ^ Spector D (05-15-13). "Deer Antler Spray: The Natural Supplement That Seems Too Good To Be True". BusinessInsider.com.
- ^ Kotz D. (31 January 2013). "Are deer antler spray and other muscle-boosting supplements safe?". Boston Globe
- ^ “Transferrin Receptor–Mediated Transcytosis in Intestinal Epithelial Cells for Gastrointestinal Absorption of Protein Drugs”. Targeted Delivery of Small and Macromolecular Drugs. Boca Ratan, Florida: CRC Press/Taylor & Francis Group. (2010). p. 32. ISBN 978-1420087727
- ^ Hernandez, Randi (2016年7月). “Are Oral Peptide Drugs on the Horizon?”. Pharm Tech. 2019年12月14日閲覧。
- ^ “S.W.A.T.S. salesman says he watched Tide players use deer spray” (英語). CBSSports.com. 2019年12月14日閲覧。
- ^ Galloway D (2013年9月5日). “Sports Performance Company Ordered to Stop Selling 'Deer Antler Spray,' Other Products”. WHNT. 2019年12月14日閲覧。
- ^ Otano J (2013年9月5日). “Ray Lewis' alleged deer antler supplier has office raided in Alabama”. SI.com. 2019年12月14日閲覧。
- ^ “Chronic wasting disease prions in elk antler velvet”. Emerging Infectious Diseases 15 (5): 696–703. (May 2009). doi:10.3201/eid1505.081458. PMC 2687044. PMID 19402954.
- ^ “A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro”. J Lab Clin Med 49 (6): 825–36. (1957). PMID 13429201.
- ^ 尾崎史郎、門田悟、中川昌一「Non Suppressible Insulin Like Activity (NSILA-s) の粗精製とインスリンレセプターアッセイによる測定法の確立」『糖尿病』第23巻第10号、日本糖尿病学会、1980年、923–929頁、doi:10.11213/tonyobyo1958.23.923。
[続きの解説]
「インスリン様成長因子1」の続きの解説一覧
- 1 インスリン様成長因子1とは
- 2 インスリン様成長因子1の概要
- 3 体内での合成と循環
- 4 関係する障害
- 5 歴史的名称
- インスリン様成長因子1のページへのリンク
